Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Left_kidney
|
| gptkbp:affects |
kidney
|
| gptkbp:associated_with |
gptkb:von_Hippel-Lindau_disease
gptkb:tuberous_sclerosis hereditary leiomyomatosis |
| gptkbp:clinical_trial |
NC T00012345
NC T00067890 NC T00123456 NC T00234567 NC T00345678 |
| gptkbp:genetic_diversity |
gptkb:MET_gene_mutation
gptkb:VHL_gene_mutation FLCN gene mutation |
| https://www.w3.org/2000/01/rdf-schema#label |
Renal cell carcinoma
|
| gptkbp:is_often_used_in |
adults
men older adults |
| gptkbp:lifespan |
leading cause of cancer death
|
| gptkbp:number_of_stages |
stage I
stage IV stage II stage III |
| gptkbp:occurs_in |
increasing incidence
|
| gptkbp:origin |
renal tubular epithelium
|
| gptkbp:research |
ongoing clinical trials
biomarker studies novel therapies |
| gptkbp:risk_factor |
hypertension
obesity smoking |
| gptkbp:screenings |
not routinely screened
|
| gptkbp:social_responsibility |
gptkb:MRI
CT scan biopsy 5-year survival rate poor prognosis in advanced stages |
| gptkbp:symptoms |
fatigue
weight loss hematuria flank pain |
| gptkbp:treatment |
gptkb:hospital
gptkb:vaccine radiation therapy targeted therapy recurrence is common after treatment response to immunotherapy varies surgical resection is curative in early stages targeted therapies improve survival |
| gptkbp:type |
gptkb:chromophobe_carcinoma
gptkb:clear_cell_carcinoma gptkb:collecting_duct_carcinoma gptkb:papillary_carcinoma |